Tiffany Crowley

Caligan Partners Lp

Assets Managed

$1.503B

Holdings

Last Quarter

2026 - Q1

Filed Date

11d ago

Growth Rate

23.71%(2Q avg: 41.41%)

Sustained Growth

6 quarters

Portfolio positions

This chart displays the top 10 holdings in Caligan Partners Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 26 positions.

Assets under management

The assets under management (AUM) of Caligan Partners Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.503B in assets, with a quarterly growth rate of 23.71% and a 2-quarter average growth rate of 41.41%. The portfolio is managed by Tiffany Crowley, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
LQDA Liquidia Corp Recent Activity	20.39%	$306.407M 8.119M shares@ $37.74 avg price
RVMD Revolution Medicines Inc Recent Activity Increased 46.57%	12.18%	$182.996M 1.882M shares@ $97.25 avg price	Increased 46.57%
ABVX Abivax Sa-adr Recent Activity Increased 0.69%	10.84%	$162.785M 1.462M shares@ $111.35 avg price	Increased 0.69%
PCVX Vaxcyte Inc Recent Activity Increased 20.88%	7.97%	$119.748M 2.061M shares@ $58.11 avg price	Increased 20.88%
XENE Xenon Pharmaceuticals Inc Recent Activity Increased 26.72%	5.4%	$81.005M 1.393M shares@ $58.15 avg price	Increased 26.72%
MLYS Mineralys Therapeutics Inc Recent Activity Decreased -45.32%	5%	$75.111M 2.773M shares@ $27.1 avg price	Decreased -45.32%
EXEL Exelixis Inc Recent Activity	4.44%	$66.619M 1.553M shares@ $42.89 avg price
CGON Cg Oncology Inc Recent Activity New Position	4.06%	$60.912M↑ Call 900,000 shares@ $67.68 avg price	New Position
TNGX Tango Therapeutics Inc Recent Activity Decreased -35.41%	3.36%	$50.392M 2.409M shares@ $20.92 avg price	Decreased -35.41%
TYRA Tyra Biosciences Inc Recent Activity Increased 35.24%	3.26%	$48.908M 1.277M shares@ $38.3 avg price	Increased 35.24%

1-10 of 26